Schonfeld Strategic Advisors LLC Eton Pharmaceuticals, Inc. Transaction History
Schonfeld Strategic Advisors LLC
- $13.8 Billion
- Q3 2024
A detailed history of Schonfeld Strategic Advisors LLC transactions in Eton Pharmaceuticals, Inc. stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 17,200 shares of ETON stock, worth $216,204. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17,200
Previous 50,917
66.22%
Holding current value
$216,204
Previous $167,000
38.32%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding ETON
# of Institutions
51Shares Held
9.44MCall Options Held
261KPut Options Held
500-
Opaleye Management Inc. Boston, MA2.78MShares$34.9 Million3.05% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.03MShares$12.9 Million0.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT999KShares$12.6 Million0.36% of portfolio
-
Westside Investment Management, Inc.619KShares$7.78 Million0.79% of portfolio
-
Acuitas Investments, LLC580KShares$7.29 Million1.66% of portfolio
About Eton Pharmaceuticals, Inc.
- Ticker ETON
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,297,000
- Market Cap $318M
- Description
- Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. The company offers Biorphen, a phenylephrine injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia; Carglumic Acid for th...